Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-038514
Filing Date
2012-06-29
Accepted
2012-06-29 16:17:04
Documents
1
Period of Report
2012-05-17

Document Format Files

Seq Description Document Type Size
1 rrd349837.html 4/A  
1 rrd349837.xml 4/A 4280
  Complete submission text file 0001181431-12-038514.txt   5802
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address
Business Address
SADOWSKI PETER L (Reporting) CIK: 0001187592 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-32302 | Film No.: 12936257